Literature DB >> 16012459

Oral bacteria in the occluded arteries of patients with Buerger disease.

Takehisa Iwai1, Yoshinori Inoue, Makoto Umeda, Yi Huang, Nobuhisa Kurihara, Morio Koike, Isao Ishikawa.   

Abstract

OBJECTIVE: Recent studies have suggested that infectious organisms play a role in vascular diseases. In this study, to explore a possible link between oral infection and Buerger disease, we investigated whether oral (periodontal) bacteria were present in occluded arteries removed from patients with characteristic Buerger disease.
METHODS: Fourteen male patients with a smoking history who had developed characteristics of Buerger disease before the age of 50 years were included in this study. Occluded arteries, including superficial femoral (n = 4), popliteal (n = 2), anterior tibial (n = 4), and posterior tibial (n = 4) arteries, were removed and studied. A periodontist performed a periodontal examination on each patient and collected dental plaque and saliva samples from them at the same time. The polymerase chain reaction method was applied to detect whether seven species of periodontal bacteria--Porphyromonas gingivalis, Tannerella forsythensis, Treponema denticola, Campylobacter rectus, Actinobacillus actinomycetemcomitans, Prevotella intermedia , and Prevotella nigrescens--were present in the occluded arteries and oral samples. In addition, arterial specimens from seven control patients were examined by polymerase chain reaction analysis.
RESULTS: DNA of oral bacteria was detected in 13 of 14 arterial samples and all oral samples of patients with Buerger disease. Treponema denticola was found in 12 arterial and all oral samples. Campylobacter rectus, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythensis, and Prevotella nigrescens were found in 14% to 43% of the arterial samples and 71% to 100% of the oral samples. A pathologic examination revealed that arterial specimens showed the characteristics of an intermediate-chronic-stage or chronic-stage lesion of Buerger disease. All 14 patients with Buerger disease had moderate to severe periodontitis. None of the control arterial samples was positive for periodontal bacteria.
CONCLUSIONS: This is the first study to identify oral microorganisms in the lesions of Buerger disease. Our findings suggest a possible etiologic link between Buerger disease and chronic infections such as oral bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012459     DOI: 10.1016/j.jvs.2005.03.016

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  38 in total

1.  Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.

Authors:  Vanda Cristina Jorge; Ana Carolina Araújo; Carla Noronha; António Panarra; Nuno Riso; Manuel Vaz Riscado
Journal:  BMJ Case Rep       Date:  2011-09-13

2.  Differential detection rate of periodontopathic bacteria in atherosclerosis.

Authors:  Takahiro Toyofuku; Yoshinori Inoue; Nobuhisa Kurihara; Toshifumi Kudo; Masatoshi Jibiki; Norihide Sugano; Makoto Umeda; Yuichi Izumi
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

Review 3.  Periodontal disease and systemic conditions: a bidirectional relationship.

Authors:  Jemin Kim; Salomon Amar
Journal:  Odontology       Date:  2006-09       Impact factor: 2.634

Review 4.  Thromboangiitis obliterans.

Authors:  Gregory Piazza; Mark A Creager
Journal:  Circulation       Date:  2010-04-27       Impact factor: 29.690

5.  Identification and characterization of prokaryotic dipeptidyl-peptidase 5 from Porphyromonas gingivalis.

Authors:  Yuko Ohara-Nemoto; Shakh M A Rouf; Mariko Naito; Amie Yanase; Fumi Tetsuo; Toshio Ono; Takeshi Kobayakawa; Yu Shimoyama; Shigenobu Kimura; Koji Nakayama; Keitarou Saiki; Kiyoshi Konishi; Takayuki K Nemoto
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

6.  An Experimental Model of Peripheral Vascular Disease Involving the Intravenous Injection of Oral Bacteria.

Authors:  Kimihiro Igari; Yoshinori Inoue; Takehisa Iwai
Journal:  Ann Vasc Dis       Date:  2016-09-26

Review 7.  Pharmacological treatment for Buerger's disease.

Authors:  Daniel G Cacione; Cristiane R Macedo; Jose C C Baptista-Silva
Journal:  Cochrane Database Syst Rev       Date:  2016-03-11

8.  A Porphyromonas gingivalis Periplasmic Novel Exopeptidase, Acylpeptidyl Oligopeptidase, Releases N-Acylated Di- and Tripeptides from Oligopeptides.

Authors:  Takayuki K Nemoto; Yuko Ohara-Nemoto; Gustavo Arruda Bezerra; Yu Shimoyama; Shigenobu Kimura
Journal:  J Biol Chem       Date:  2016-01-05       Impact factor: 5.157

9.  Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease.

Authors:  Zhiyong Chen; Megumi Takahashi; Taeko Naruse; Toshiaki Nakajima; Yi-Wen Chen; Yoshinori Inoue; Isao Ishikawa; Takehisa Iwai; Akinori Kimura
Journal:  Hum Genet       Date:  2007-07-25       Impact factor: 4.132

10.  Are There Any Objections against Our Hypothesis That Buerger Disease Is an Infectious Disease?

Authors:  Takehisa Iwai; Makoto Umeda; Yoshinori Inoue
Journal:  Ann Vasc Dis       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.